154 related articles for article (PubMed ID: 36555172)
1. Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers.
Dhakal A; Upadhyay R; Wheeler C; Hoyd R; Karivedu V; Gamez ME; Valentin S; Vanputten M; Bhateja P; Bonomi M; Konieczkowski DJ; Baliga S; Mitchell DL; Grecula JC; Blakaj DM; Denko NC; Jhawar SR; Spakowicz D
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555172
[TBL] [Abstract][Full Text] [Related]
2. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.
Li H; Torabi SJ; Yarbrough WG; Mehra S; Osborn HA; Judson B
JAMA Otolaryngol Head Neck Surg; 2018 Jun; 144(6):519-525. PubMed ID: 29801040
[TBL] [Abstract][Full Text] [Related]
3. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ
Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957
[TBL] [Abstract][Full Text] [Related]
4. All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
Kim HAJ; Zeng PYF; Shaikh MH; Mundi N; Ghasemi F; Di Gravio E; Khan H; MacNeil D; Khan MI; Patel K; Mendez A; Yoo J; Fung K; Lang P; Palma DA; Mymryk JS; Barrett JW; Boutros PC; Nichols AC
Oral Oncol; 2021 May; 116():105260. PubMed ID: 33725617
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survival.
Upadhyay R; Dhakal A; Wheeler C; Hoyd R; Jagjit Singh M; Karivedu V; Bhateja P; Bonomi M; Valentin S; Gamez ME; Konieczkowski DJ; Baliga S; Grecula JC; Blakaj DM; Gogineni E; Mitchell DL; Denko NC; Spakowicz D; Jhawar SR
Cancer Biol Ther; 2024 Dec; 25(1):2350249. PubMed ID: 38722731
[TBL] [Abstract][Full Text] [Related]
6. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
7. Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer.
Hayes RB; Ahn J; Fan X; Peters BA; Ma Y; Yang L; Agalliu I; Burk RD; Ganly I; Purdue MP; Freedman ND; Gapstur SM; Pei Z
JAMA Oncol; 2018 Mar; 4(3):358-365. PubMed ID: 29327043
[TBL] [Abstract][Full Text] [Related]
8. Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
Chan JYK; Cheung MK; Lan L; Ng C; Lau EHL; Yeung ZWC; Wong EWY; Leung L; Qu X; Cai L; Zhu H; Boon SS; Burk RD; Chan PKS; Chen Z
Oral Oncol; 2022 Dec; 135():106245. PubMed ID: 36375420
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
10. Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients.
Koyuncu CF; Frederick MJ; Thompson LDR; Corredor G; Khalighi S; Zhang Z; Song B; Lu C; Nag R; Sankar Viswanathan V; Gilkey M; Yang K; Koyfman SA; Chute DJ; Castro P; Lewis JS; Madabhushi A; Sandulache VC
Oral Oncol; 2023 Aug; 143():106459. PubMed ID: 37307602
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
12. Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
Saksø M; Mortensen LS; Primdahl H; Johansen J; Kallehauge J; Hansen CR; Overgaard J
Radiother Oncol; 2020 Oct; 151():126-133. PubMed ID: 32805273
[TBL] [Abstract][Full Text] [Related]
13. Variations in the association of grade with survival across the head and neck cancer landscape.
Anderson EM; Luu M; Balzer BL; Scher KS; Mita AC; Lu DJ; Shiao SL; Clair JM; Ho AS; Zumsteg ZS
Head Neck; 2021 Apr; 43(4):1105-1115. PubMed ID: 33300641
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
15. High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients.
Scheiflinger A; Al-Gboore S; Jank BJ; Brkic F; Kadletz-Wanke L; Kenner L; Heiduschka G; Schnoell J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10675-10683. PubMed ID: 37308746
[TBL] [Abstract][Full Text] [Related]
16. Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck.
Antonsson A; Law MH; Neale RE; Coman WB; Pryor DI; ; Porceddu SV; Whiteman DC
Cancer Causes Control; 2016 Jun; 27(6):809-15. PubMed ID: 27097911
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
[TBL] [Abstract][Full Text] [Related]
18. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
19. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
20. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]